174例男性不育症患者精浆微量元素检测与分析

检测了174例男性不育症患者精浆锌、铁、铅、钙、镁等五种微量元素,以探讨不育症患者精浆微量元素含量与精液质量的关系。结果显示：（1）粘稠性精液组精浆锌含量显著低于正常粘度精液组（P＜0．01）,精浆钙含量低于正常度精液组（P＜0．05）,铁、铅、镁含量无差异（P＜0．05）。（2）无精子及少精子症组精浆铁、钙含量高于精子密度正常组（P＜0．01）,铜含量低于精子密度正常组（P＜0．01）,锌、镁含量无差异（P＜0．05）。（3）精子活动率低下组与正常组浆微量元素含量无差异（P＜0．05）。提示精浆锌、铁、铅、钙等微量元素含量改变是影响精液质量的重要原因之一。精浆镁含量与精液质量似无明显关系。     

视网膜脱离后PVR的形成与氧自由基和锌、铜关系的研究

为探讨氧自由基和锌、铜在视网膜脱离后增殖性玻璃体视网膜病变 (PVR)中的作用 ,收集了 48例视网膜脱离患者视网膜下液 (SRF) ,利用紫外分光光度计测定了SRF中LPO的含量和SOD的活性 ,用原子吸收光谱法测定了Zn、Cu的含量。结果表明 ,随着PVR程度及玻璃体浑浊的加重、病程的延长 ,LPO含量增加 ,SOD活性明显下降 ,P <0 0 5 ,差异有统计学意义。提示SRF中LPO、Zn、Cu含量及SOD活性的改变与视网膜脱离后PVR的发生、发展有密切关系。     

男性不育患者精液白细胞、巨噬细胞与锌的研究

为探讨男性不育患者精液白细胞、巨噬细胞与锌的关系,研究测定了85例男性不育患者精液白细胞、巨噬细胞和精浆锌的含量.结果提示,不育男性中精液白细胞≥106/mL组与精浆锌之间有显著性差异（P＜0.01）：精浆锌含量与巨噬细胞阳性组差异有显著性（P＜0.05）,说明精液白细胞、巨噬细胞可能对精浆锌的含量有一定的影响.     

低剂量硝酸镧对小鼠肾脏自由基防御机能的影响

通过采用肾组织匀浆生化测定法, 观察不同剂量硝酸镧灌胃一个月后, 小鼠肾组织中超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、脂质过氧化物(LPO)、谷胱甘肽过氧化物酶(GSH-PX)含量的变化, 探讨了低剂量硝酸镧的抗氧化作用; 结果表明 雌性、雄性小鼠20.0, 10.0 mg*kg-1 Cu-ZnSOD和CAT的含量均较对照组明显降低; 而GSH-Px和LPO的含量均较对照组显著升高. 雌性、雄性小鼠0.1, 0.2, 2.0 mg*kg-1组Cu-ZnSOD, CAT, GSH-Px和LPO的含量与对照组无显著性差异. 较高剂量(20.0, 10.0 mg*kg-1)的硝酸镧的直接损伤可使小鼠肾脏脂质过氧化反应增强, 清除自由基的能力下降. 较低剂量(0.1, 0.2, 2.0 mg*kg-1)的硝酸镧对小鼠肾脏自由基的生成和清除无影响.     

乙型肝炎患者血清中SOD与LPO含量分析

为了研究乙型肝炎患者血清中超氧化物歧化酶（SOD）活性水平、过氧化脂质（LPO）含量及其变化规律,应用黄嘌吟氧化酶法和硫代巴比妥酸法测定了53例乙肝患者血清中SOD与LPO含量,其中急性乙型肝炎（急肝）35例,慢性活动性乙型肝炎（慢活肝）18例。结果表明,乙型肝炎患者（包括急肝、慢活肝）血清中SOD的含量高于正常对照组（P＜0．05）,而LPO的含量也高于对照组（P＜0．01）,具有显著性差异,提示乙型肝炎患者体内存在着自由基紊乱。     

化学计量学-分光光度法同时测定成年男子精液中的钙、镁、锌

在pH10．4的硼砂-NaOH缓冲体系中,2-(8′-羟基喹啉-5′-磺酸-7′-偶氮)变色酸(8Q5SAC)能分别与钙、镁、锌形成络合物。它们的光谱均在400～800nm波长范围内,且相互重叠。本文应用主成分回归法、偏最小二乘法和径向基人工神经网络法处理测量数据,建立数学模型,并对一组人工合成试样作浓度预报,发现径向基人工神经网络法能给出最好的结果,钙、镁和锌测定的RSD分别为3．4％、3．0％、3．2％。将此法用于一患不育症成年男子和一正常成年男子精液中的钙、镁、锌同时测定,荻较好结果。     

男性不育患者精浆锌含量的分析

为探讨锌与男性不育患者的关系 ,本文研究测定了 173例男性不育患者精浆锌的含量 ,同时与正常生育男性进行比较。结果显示 ,正常生育男性与不育男性中少精子症、精子活率 <55%、活动力Ⅲ、Ⅳ级 <2 5% ,梗阻性无精子症 ,精液白细胞≥ 10 6 mL之间均有显著性差异。说明锌对男性生育过程起相当重要的作用 ,它在精浆中含量的变化可能是导致男性不育的原因之一。     

含胺基功能性单体的聚合研究——Ⅱ.甲基丙烯酸N,N-二甲氨基乙酯在过氧化月桂酰引发下的聚合

研究了甲基丙烯酸N,N-二甲氨基乙酯(DMAEMA)在过氧化月桂酰(LPO)引发下的聚合动力学。求出了在40、50、60和70℃下的表观聚合速率。得到其聚合速度方程式为: Rp-Kp[DMAEMA]~(1.5)[LPO]~(0.5)其表现聚合活化能E_a为9.7 kcal/mol,并提出了含脂肪叔胺基单体参与氧化还原引发体系而引发其自身单体聚合的历程。     

含胺基功能性单体的聚合研究 Ⅴ.4-N,N-二甲胺基苯乙烯的合成及其作为氧化还原引发体系组分的研究

<正> 前文我们报告了含有芳香叔胺基的丙烯酸酯、甲基丙烯酸-4-N,N-二甲氨基苄酯(DMABMA)在过氧化二月桂酰(LPO)引发下的聚合动力学。从所得的聚合速度方程式及低的聚合活化能,认为DMABMA与LPO形成氧化还原体系而使DMABMA聚合,在本文第Ⅳ报中报道了DMABMA不仅能引发甲基丙烯酸甲酯的聚合,还参与聚甲基丙烯酸甲酯的链中,因此称这种既能参与引发聚合反应,又参与聚合物链中的引发“引发剂单体(initiatomer)”。这种含有可聚合胺引发体系的优点是,用于丙烯酸酯类医用     

甲基丙烯酸-β-羟基-γ-二烷氨基丙酯的合成及聚合

由甲基丙烯酸失水甘油酯与三烷基胺合成了甲基丙烯酸-2-羟基-3-二甲氨基丙酯(DMAHPMA)及甲基丙烯酸-2-羟基-3-二乙氨基丙酯(DEAHPMA),并进行了在各种自由基引发剂下的本体聚合。发现BPO不能使之聚合,其它过氧化物,如LPO,TBH,CHP,KPS等能引发聚合。测定了DEAHPMA在CHP,LPO,AIBN引发下的初期聚合速度Rp,并计算出它们的聚合活化能,据此,认为CHP,LPO以氧化还原机理引发DEAHPMA的聚合。 DMAHPMA在10％的盐水溶液中,不加悬浮稳定剂,即能成功地进行悬浮聚合。     

Determination of coenzyme Q10 in human seminal plasma by high-performance liquid chromatography and its clinical application

A high-performance liquid chromatographic (HPLC) method for the analysis of coenzyme Q10 (CoQ10) in human seminal plasma was developed and applied to investigate its clinical significance as a reference index relating to oxidative stress and infertile status of spermatozoa. After precipitation of proteins in seminal plasma with methanol, CoQ10 and coenzyme Q9 (CoQ9; internal standard) were extracted with hexane. The supernatant after centrifugation was evaporated to dryness with nitrogen at 45 degrees C. The residue was re-dissolved in isopropanol. HPLC separation of the sample solution was performed on a Lichrospher C(18) column with a mobile phase composed of isopropanol-methanol-tetrahydrofuran in the ratio of 55:39:6 (v/v/v) at a flow rate of 1.0 mL/min. Under the chromatographic conditions described, the CoQ10 and CoQ9 had retention times of approximately 5.83 and 4.97 min, respectively. The peaks were detected at UV 275 nm. Good separation and detectability of CoQ10 in human seminal plasma were obtained. The method was linear in the range 0.01-10.00 microg/mL. The relative standard deviations within- and between-assay for CoQ10 analysis were 0.85 and 1.86%, respectively. The average recoveries were 94.1-99.0% for the human seminal plasma samples. The CoQ10 levels in seminal plasma of 195 patients and 23 control subjects were studied. CoQ10 concentrations in the two populations were: 37.1 +/- 12.2 ng/mL in the fertile group and 48.5 +/- 20.4 ng/mL in the infertile group. The large difference (p < 0.01) between the fertile and infertile populations is evident.     

高效液相色谱-程序波长紫外检测法同时测定血浆中的色氨酸及其代谢物

建立了一种高效液相色谱-程序波长紫外检测法同时测定血浆中色氨酸(Trp)及其主要代谢产物犬尿氨酸(Kyn)和5-羟色胺(5-HT)。以茶碱为内标(IS),采用BDS-Hypersil-C8柱(150 mm×4.6 mm, 5 μm)分离。流动相为10 mmol/L醋酸钠缓冲液(pH 4.5)-乙腈(94:6, v/v),流速为0.6 mL/min;柱温为25 ℃;紫外检测波长设定: Kyn和IS为360 nm, 5-HT为220 nm, Trp为302 nm。3种物质的平均回收率为87%～113%;线性范围分别为3.97～400 μmol/L(Trp), 0.421～20.2 μmol/L(Kyn), 4.36～980 nmol/L(5-HT);检出限分别为0.134 μmol/L(Trp), 0.0160 μmol/L(Kyn), 2.03 nmol/L(5-HT)。利用该方法对15例抑郁症患者和15例健康志愿者的血浆进行测定,结果表明两组间Trp的代谢存在显著的差异。     

Ultrasensitive detection of malondialdehyde with surface-enhanced Raman spectroscopy

Malondialdehyde (MDA) is a biomarker of lipid peroxidation that has been widely associated with food rancidity as well as many human diseases. Most current MDA detection methods involve MDA reaction with thiobarbituric acid (TBA), followed by UV-visible and/or fluorescence detection of high-performance liquid chromatography (HPLC)-separated TBA-MDA. Herein, we report the first proof-of-concept study of surface-enhanced Raman detection of a TBA-MDA adduct using silver nanoparticles as the SERS substrate and the 632.8 nm HeNe laser as a Raman excitation source. Current SERS detection limit of TBA-MDA is 0.45 nM, ~100 times higher than the 36 nM fluorescence sensitivity recently reported with the HPLC-purified TBA-MDA. Molecular specificity of the SERS technique was studied by comparing the SERS spectrum of TBA-MDA with those acquired with TBA adducts of other TBA-reactive compounds (TBARCs) that includes formaldehyde, acetaldehyde, butyraldehyde, trans-2-hexenal, and pyrimidine. Compared to TBA and TBA adducts with those TBARCs, the SERS activity of TBA-MDA adduct is significantly higher. The possibility of direct SERS detection of TBA-MDA in a reaction mixture (without HPLC separation) has also been investigated.     

反相离子对色谱-电感耦合等离子体质谱联用技术测定水中痕量Cr(Ⅲ)与Cr(Ⅵ)

建立了反相离子对色谱(RPIPC)与电感耦合等离子体质谱(ICP-MS)联用技术快速分离测定水中痕量Cr(Ⅲ)和Cr(Ⅵ)的方法.通过考察流动相的pH值、离子对试剂及甲醇的浓度和EDTA的添加等对不同形态铬的保留时间及分离度的影响,确定当流动相组成为2.0 mmol/L TBA,5%(V/V)甲醇,pH=5.5时,Cr(Ⅲ)与Cr(Ⅵ)可达最佳分离.ICP-MS测定时选用碰撞池技术以消除40Ar12C+与35Cl16OH+对52Cr+的谱学干扰;进样100 μL时,Cr(Ⅲ)与Cr(Ⅵ)的检出限分别为0.15 μg/L和0.16 μg/L.加标回收率在93.6%～106.2%之间; RSD<4%(n=3).以本方法分析了某市自来水、雨水及某品牌纯净水中Cr(Ⅲ)与Cr(Ⅵ)的含量,结果令人满意.     

Quantification of malondialdehyde by HPLC‐FL – application to various biological samples

Malondialdehyde (MDA) is stabile product of lipid peroxidation (LPO), and therefore MDA is frequently used as a biomarker of LPO. To determine MDA level in various biological samples (human plasma, fish liver tissue and cells in culture), we used an HPLC method with fluorescent detection based on 2‐thiobarbituric acid (TBA) assay. The method was validated by the use of spiked pooled plasma samples. In tested concentration range (0.15–3.0 µmol/L) the method was linear (R² = 0.9963), the between‐day variability (coefficient of variations, CVs) was between 4.7 and 7.6%, the within‐day variability CVs was between 2.6 and 6.4% and recovery was between 91.2 and 107.6%. The level of MDA in human plasma (healthy male, non‐smokers, 46.3 ± 4.7 years; N = 38) was 2.2 ± 1.4 µmol/L; that in liver tissue of common carp (Cyprinus carpio; N = 12) was 0.02 ± 0.004 µmol/g tissue, and in cultured cells (human laryngeal carcinoma cells; N = 10) it was 0.18 ± 0.02 nmol/mg proteins. The HPLC‐FL method is rapid, accurate and reliable to follow the extent of LPO in various biological samples, particularly in samples in which a low level of MDA is expected, such as cells in culture. Owing to the rapid analytical process and run time, it can be used for routine analysis of MDA in clinical laboratory. Copyright © 2014 John Wiley & Sons, Ltd.     

Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography

A simple and selective HPLC assay was developed and utilized for determination of human plasma protein binding of baicalin. The method involved solid-phase extraction and reversed-phase chromatographic separation with a mobile phase of acetonitrile-0.02 mol/L phosphate buffer (pH 2.5; 25:75, v/v) and UV detection at 276 nm. The standard curve for baicalin was linear over the concentration range 0.1-20 microg/mL and the limit of detection was 0.02 microg/mL. The absolute recovery was greater than 76%. The intra-day and inter-day variations were less than 10%. Ultrafiltration technique was applied to determining the plasma protein binding of baicalin in human plasma. Results show the plasma protein binding of baicalin was in the range 86-92% over all the concentrations studied and the protein binding association constant was determined to be 1.21 x 10(5) L/mol at 4 degrees C.     

Development and validation of HPLC method for the determination of α-tocopherol in human erythrocytes for clinical applications

In this work, a simple isocratic reversed-phase HPLC method for determination of alpha-tocopherol in human erythrocytes has been developed and validated. After separation of plasma the erythrocytes were washed three times with 0.9% sodium chloride containing 0.01% butylated hydroxytoluene (BHT) as antioxidant and then were diluted 1:1 (v/v) with the same solution. In the liquid-liquid extraction (LLE) procedure, 2500 microL of n-hexane was added to 500 microL of erythrocytes. After 2 min this mixture was deproteinized by addition of cool ethanol (500 microL, 5 min) denatured with 5% methanol containing alpha-tocopherol acetate (20 micromol L(-1)), as internal standard, and then extracted for 5 min by vortex mixing. After centrifugation (10 min, 1600xg) an aliquot (2000 microL) of the clean extract was separated and evaporated under nitrogen. The residue was dissolved in 400 microL methanol and analysed by reversed-phase HPLC on a 4.6 mmx150 mm, 5 microm Pecosphere C18 column; the mobile phase was 100% methanol, flow rate 1.2 mL min(-1). The volume injected was 100 microL and detection was by diode-array detector at a wavelength of 295 nm. The extraction recovery of alpha-tocopherol from human erythrocytes was 100.0+/-2.0%. The detection limit was 0.1 micromol L(-1) and a linear calibration plot was obtained in the concentration range 0.5-20.0 micromol L(-1). Within determination precision was 5.2% RSD (n=10), between determination precision was 6.1% RSD (n=10). The method was applied successfully in a clinical study of patients with acute pancreatitis and for determination of the reference values in the healthy Czech population.     

HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humans

A simple and sensitive reversed-phase high performance liquid chromatographic method (HPLC) has been developed and validated for the routine analysis of diltiazem in human plasma and the study of the pharmacokinetics of the drug in the human body. Diltiazem and diazepa (internal standard) were extracted with a mixed organic solution of hexane, chloroform and isopropanol (60:40:5, v/v/v), and then HPLC separation of the drugs was performed on an Spherisorb C(18) column and detected by ultraviolet absorbance at 239 nm. The use of methanol-water solution (containing 2.8 mm triethylamine, 80:20, v/v) as the mobile phase at a fl ow-rate of 1.2 mL/min enables the baseline separation of the drugs free from interferences with isocratic elution. The method was linear in the clinical range 0-300 ng/mL and the lower limit of detection of diltiazem in plasma was 3 ng/mL. The range of percentage of relative standard deviation (%RSD) was from 3.5 to 6.8% for within-day analyses and from 6.2 to 8.4% for between-day analyses, respectively. The extraction recoveries of diltiazem from spiked human plasma (n = 5) at three concentrations were 91.4-104.0%. The method has been used to determine diltiazem in human plasma samples from eight volunteers who had taken diltiazem hydrochloride slow release tables and the data obtained was fitted with a program on computer to study the pharmacokinetics. The results showed that the peak level in plasma approximately averaged 118.5 +/- 14.3 ng/mL at 3.1 +/- 0.4 h, and the areas under the drug concentration curves (AUC) was 793.1 +/- 83.1 ng.h/mL.     

Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector

A rapid and simple high-performance liquid chromatography (HPLC) method was developed and validated for the quantification of clindamycin in human plasma. After precipitation with 50% trichloroacetic acid (TCA) containing the internal standard, propranolol, the analysis of the clindamycin level in the plasma samples was carried out using a reverse-phase cyano (CN) column with ultraviolet detection (204 nm). The chromatographic separation was accomplished with an isocratic mobile phase consisting of acetonitrile-distilled water-7.6 mm tetramethylammonium chloride (TMA) (60:40:0.075, v/v/v), adjusted to pH 3.2. The proposed method was specific and sensitive with a lower limit of quantitation (LLOQ) of 0.2 microg/mL. This HPLC method was validated by examining the precision and accuracy for inter- and intraday analysis in the concentration range 0.2-20.0 microg/mL. The relative standard deviations (RSD) in the inter- and intraday validation were 6.1-14.9 and 6.0-16.1%, respectively. In the stability test, clindamycin was found to be stable in human plasma during the storage and assay procedure. The present HPLC method was applied to the analysis of samples taken up to 12 h after a single oral administration of clindamycin in healthy volunteers.     

High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma

A simple high-performance liquid chromatographic (HPLC) method was developed and validated for rapid quantification of linezolid in human plasma. Protein precipitation using a mixture of 5% trichloroacetic acid and methanol (3:1, v/v) provided a straightforward method of sample preparation and the internal standard eperezolid was employed. A concentration range from 0.20 to 40.0 mg/L was utilized to construct calibration curves, and analysis of low- (0.40 mg/L), medium- (7.50 mg/L) and high-quality (25.0 mg/L) control samples revealed excellent reproducibility (相似文献